Drug Database
Back to search

Netherlands· NL-3b5d52365477

PegIntron 100 microgram poeder en oplosmiddel voor oplossing voor injectie

A peginterferon alfa-2b product containing peginterferon alfa-2b, registered in Netherlands by Merck Sharp & Dohme B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC L03AB10

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedPegIntron 100 microgram poeder en opl…ATCL03AB10REGISTER NO.NL-3b5d52365477PACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about peginterferon alfa-2bAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Peginterferon alfa-2b is registered in 5 of 19 countries.

Countries holding a registration under ATC L03AB10 (peginterferon alfa-2b), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 2 of them publish a price we can compare per daily dose
Search peginterferon alfa-2b products by name

Peginterferon alfa-2b · ATC L03AB10

5 / 19 countries

  • Belgiumprice
  • Denmark
  • Finlandprice
  • Netherlands
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
PEGINTERFERON ALFA-2B
Manufacturer
Merck Sharp & Dohme B.V.
Country
Netherlands (NL)
ATC code
L03AB10
ATC class
Peginterferon alfa-2b
Defined daily dose
15 mcg, P
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/00/131

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

199 interactions on record for peginterferon alfa-2b.

Graded by severity as the source publishes them — 36 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check peginterferon alfa-2b against other medicinesHow interaction checks work

Peginterferon alfa-2b · interactions on record

199 records

  • 36 severe
  • 161 moderate
  • 2 minor

Most severe, free to view

  • EltrombopagB02BX05severe
  • MipomersenC10AX11severe
  • LomitapideC10AX12severe
  • ZidovudineJ05AF01severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Peginterferon alfa-2b in 5 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All peginterferon alfa-2b products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d5ab9f99-a831-4cc5-88b0-c19d325bdd5a
GET /v1/drugs/d5ab9f99-a831-4cc5-88b0-c19d325bdd5a?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder en oplosmiddel voor oplossing voor injectie",
  "route": "Subcutaan gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/pegintron-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Peginterferon Alfa-2b",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp71026",
  "excipients": [
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "POLYSORBAAT 80 (E 433)",
    "SACCHAROSE",
    "STIKSTOF (HEAD SPACE) (E 941)",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "PEGINTERFERON ALFA-2B"
  ],
  "leaflet_url": null,
  "authorised_at": "2000/05/25",
  "procedure_number": "EMEA/H/C/000280",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/00/131",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about peginterferon alfa-2b.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console